Latest News for: five (ep)

Edit

3 Reasons We’re Fans of AAON (AAON)

The Call 28 Mar 2025
Over the last five years, AAON grew its sales at an incredible 20.7% compounded annual growth rate ... AAON’s EPS grew at an astounding 23.5% compounded annual growth rate over the last five years, higher than its 20.7% annualized revenue growth.
Edit

BrightView (BV): Buy, Sell, or Hold Post Q4 Earnings?

The Call 28 Mar 2025
Over the last five years, BrightView grew its sales at a sluggish 2.3% compounded annual growth rate ... EPS Trending Down ... Sadly for BrightView, its EPS declined by 6.5% annually over the last five years while its revenue grew by 2.3%.
Edit

3 Big Reasons to Love Curtiss-Wright (CW)

The Call 28 Mar 2025
EPS Moving Up Steadily ... Curtiss-Wright’s EPS grew at a decent 8.1% compounded annual growth rate over the last five years, higher than its 4.6% annualized revenue growth ... over the last five years.
Edit

Amphenol (APH): Buy, Sell, or Hold Post Q4 Earnings?

The Call 28 Mar 2025
Over the last five ... Outstanding Long-Term EPS Growth ... Amphenol’s EPS grew at an astounding 15.1% compounded annual growth rate over the last five years, higher than its 13.1% annualized revenue growth.
Edit

3 Reasons to Sell MATW and 1 Stock to Buy Instead

The Call 28 Mar 2025
Over the last five years, Matthews grew its sales at a weak 2.7% compounded annual growth rate ... EPS Trending Down ... Sadly for Matthews, its EPS declined by 10% annually over the last five years while its revenue grew by 2.7%.
Edit

2 Reasons to Like BR and 1 to Stay Skeptical

The Call 28 Mar 2025
Over the last five years, Broadridge grew its sales at a solid 9% compounded annual growth rate ... Broadridge’s EPS grew at a spectacular 12.8% compounded annual growth rate over the last five years, higher than its 9% annualized revenue growth.
Edit

3 Big Reasons to Love HCA Healthcare (HCA)

The Call 28 Mar 2025
Outstanding Long-Term EPS Growth ... HCA Healthcare’s EPS grew at an astounding 15.9% compounded annual growth rate over the last five years, higher than its 6.6% annualized revenue growth ... five years.
Edit

3 Reasons RTX is Risky and 1 Stock to Buy Instead

The Call 28 Mar 2025
EPS Trending Down. We track the long-term change in earnings per share (EPS) because it highlights whether a company’s growth is profitable. Sadly for RTX, its EPS declined by 1.9% annually over the last five years while its revenue grew by 9.2%.
Edit

Artivion (AORT): Buy, Sell, or Hold Post Q4 Earnings?

The Call 28 Mar 2025
Regrettably, Artivion’s sales grew at a mediocre 7.1% compounded annual growth rate over the last five years ... EPS Trending Down ... Sadly for Artivion, its EPS declined by 5.1% annually over the last five years while its revenue grew by 7.1%.
Edit

3 Reasons MIDD is Risky and 1 Stock to Buy Instead

The Call 28 Mar 2025
EPS Barely Growing ... Middleby’s unimpressive 6% annual EPS growth over the last five years aligns with its revenue performance ... As you can see below, Middleby’s margin dropped by 3 percentage points over the last five years.
Edit

BGYO releases self-titled EP

The Philippine Star 28 Mar 2025
P-pop group BGYO recently launched a self-titled EP featuring five tracks, including their latest music video “Divine.” ....
Edit

1 Restaurant Stock with Exciting Potential and 2 to Turn Down

The Call 28 Mar 2025
... of 18.6% is below its competitors, leaving less money for marketing and promotionsEarnings growth underperformed the sector average over the last five years as its EPS grew by just 4.4% annually.
Edit

The Challenge fans blast All Stars Rivals cast and format for ‘stupidity’ after elimination move

Monsters & Critics 28 Mar 2025
A teaser trailer revealed that the next episode would trim the teams from five to four finalists. Promo for next week's ep 👀👀👀👀 #TheChallengeAllStars5 #TheChallengeAS5 #TheChallengeAS ...
Edit

AAR (NYSE:AIR) Misses Q1 Sales Targets

The Call 27 Mar 2025
... miss)Adjusted EPS ... AAR’s EPS grew at an unimpressive 7.2% compounded annual growth rate over the last five years ... For AAR, its two-year annual EPS growth of 13.8% was higher than its five-year trend.
Edit

Winnebago’s (NYSE:WGO) Q1: Beats On Revenue But Full-Year Sales Guidance Misses Expectations

The Call 27 Mar 2025
$620.2 million vs analyst estimates of $616.7 million (11.9% year-on-year decline, 0.6% beat)Adjusted EPS ... Sadly for Winnebago, its EPS declined by 15.2% annually over the last five years while its revenue grew by 3.9%.
×